{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T06:44:03Z","timestamp":1785912243061,"version":"3.56.0"},"reference-count":235,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T00:00:00Z","timestamp":1619049600000},"content-version":"am","delay-in-days":295,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP20dm0107119"],"award-info":[{"award-number":["JP20dm0107119"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17H04243"],"award-info":[{"award-number":["17H04243"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19H05203"],"award-info":[{"award-number":["19H05203"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.bbi.2020.04.046","type":"journal-article","created":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T11:45:47Z","timestamp":1587555947000},"page":"59-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":230,"special_numbering":"C","title":["Current status of potential therapeutic candidates for the COVID-19 crisis"],"prefix":"10.1016","volume":"87","author":[{"given":"Jiancheng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2020.04.046_b0005","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1212\/WNL.49.3.899-b","article-title":"Complications of intravenous gammaglobulin in neuromuscular diseases","volume":"49","author":"Achiron","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.bbi.2020.04.046_b0015","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1182\/blood-2004-04-1559","article-title":"Human mesenchymal stem cells modulate allogeneic immune cell responses","volume":"105","author":"Aggarwal","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbi.2020.04.046_b0020","doi-asserted-by":"crossref","first-page":"e00221","DOI":"10.1128\/mBio.00221-18","article-title":"Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease","volume":"9","author":"Agostini","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.bbi.2020.04.046_b0025","doi-asserted-by":"crossref","first-page":"e01348","DOI":"10.1128\/JVI.01348-19","article-title":"Small-molecule antiviral \u03b2-d\u2013hydroxycytidine inhibits a proofreading-intact coronavirus with a high genetic barrier to resistance","volume":"93","author":"Agostini","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.bbi.2020.04.046_b0030","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4014\/jmb.2003.03011","article-title":"Current status of epidemiology, diagnosis, therapeutics, and vaccines for novel coronavirus disease 2019 (COVID-19)","volume":"30","author":"Ahn","year":"2020","journal-title":"J. Microbiol. Biotechnol."},{"key":"10.1016\/j.bbi.2020.04.046_b0035","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1128\/JVI.79.3.1966-1969.2005","article-title":"Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus","volume":"79","author":"Akerstr\u00f6m","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.bbi.2020.04.046_b0040","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s40265-018-0908-4","article-title":"Baricitinib: A review in rheumatoid arthritis","volume":"78","author":"Al-Salama","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.bbi.2020.04.046_b0045","doi-asserted-by":"crossref","unstructured":"Anderson, D.E., Cui, J., Ye, Q., Huang, B.Y., Zu, W.H., Gong, J., Liu, W.Q., Kim, S.Y., Yan, B.G., Sigmundsson, K., Lim, X.F., Ye, F., Niu, P.H., Zhou, X.M., Tan, W.J., Wang, L.F., Tan, X., 2020. Orthogonal genome-wide screenings in bat cells identify MTHFD1 as a target of broad antiviral therapy. bioRxiv, 2020.2003.2029.014209.","DOI":"10.1101\/2020.03.29.014209"},{"key":"10.1016\/j.bbi.2020.04.046_b0050","first-page":"372","article-title":"Human intravenous immunoglobulin modulates monokine production in vitro","volume":"71","author":"Andersson","year":"1990","journal-title":"Immunology"},{"key":"10.1016\/j.bbi.2020.04.046_b0055","first-page":"211","article-title":"Down-regulation of cytokine production and interleukin-2 receptor expression by pooled human IgG","volume":"79","author":"Andersson","year":"1993","journal-title":"Immunology"},{"key":"10.1016\/j.bbi.2020.04.046_b0060","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1164\/rccm.201706-1172OC","article-title":"Corticosteroid therapy for critically ill patients with middle east respiratory syndrome","volume":"197","author":"Arabi","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.bbi.2020.04.046_b0065","doi-asserted-by":"crossref","first-page":"881","DOI":"10.2310\/JIM.0b013e31821b8755","article-title":"Vitamin D and the immune system","volume":"59","author":"Aranow","year":"2011","journal-title":"J. Investig. Med."},{"key":"10.1016\/j.bbi.2020.04.046_b0070","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1136\/thoraxjnl-2013-204980","article-title":"Human mesenchymal stem cells reduce the severity of acute lung injury in a sheep model of bacterial pneumonia","volume":"69","author":"Asmussen","year":"2014","journal-title":"Thorax"},{"key":"10.1016\/j.bbi.2020.04.046_b0075","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1016\/S0140-6736(20)30309-3","article-title":"2019-nCoV epidemic: address mental health care to empower society","volume":"395","author":"Bao","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.bbi.2020.04.046_b0080","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1517\/14656566.9.13.2363","article-title":"Lopinavir\/ritonavir: a protease inhibitor for HIV-1 treatment","volume":"9","author":"Barragan","year":"2008","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.bbi.2020.04.046_b0085","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/(SICI)1097-4598(199603)19:3<388::AID-MUS20>3.0.CO;2-N","article-title":"Complications of intravenous gammaglobulin in neuromuscular and other diseases","volume":"19","author":"Bertorini","year":"1996","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.bbi.2020.04.046_b0090","unstructured":"BioSpace. April 07, 2020. FDA clears the way for ridgeback biotherapeutics to begin human testing of a promising potential treatment for COVID-19."},{"key":"10.1016\/j.bbi.2020.04.046_b0095","article-title":"The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro","volume":"104787","author":"Caly","year":"2020","journal-title":"Antiviral Res."},{"key":"10.1016\/j.bbi.2020.04.046_b0100","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2001282","article-title":"A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19","author":"Cao","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbi.2020.04.046_b0105","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.3390\/nu9111211","article-title":"Vitamin C and Immune Function","volume":"9","author":"Carr","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.bbi.2020.04.046_b0110","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/s13054-017-1891-y","article-title":"Hypovitaminosis C and vitamin C deficiency in critically ill patients despite recommended enteral and parenteral intakes","volume":"21","author":"Carr","year":"2017","journal-title":"Crit. Care"},{"key":"10.1016\/j.bbi.2020.04.046_b0115","unstructured":"Celularity. April 02, 2020. Celularity announces FDA clearance of IND application for CYNK-001 in coronavirus, first in cellular therapy. https:\/\/www.prnewswire.com\/news-releases\/celularity-announces-fda-clearance-of-ind-application-for-cynk-001-in-coronavirus-first-in-cellular-therapy-301034141.html."},{"key":"10.1016\/j.bbi.2020.04.046_b0120","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1634\/stemcells.2007-0197","article-title":"Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing","volume":"25","author":"Chamberlain","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.bbi.2020.04.046_b0125","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/22221751.2020.1719902","article-title":"Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan","volume":"9","author":"Chan","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.bbi.2020.04.046_b0130","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1172\/JCI126363","article-title":"IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes","volume":"130","author":"Channappanavar","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbi.2020.04.046_b0135","doi-asserted-by":"crossref","unstructured":"Chen, C., Huang, J., Cheng, Z., Wu, J., Chen, S., Zhang, Y., Chen, B., Lu, M., Luo, Y., Zhang, J., Yin, P., Wang, X., 2020a. Favipiravir versus arbidol for COVID-19: a randomized clinical trial. medRxiv, 2020.2003.2017.20037432.","DOI":"10.1101\/2020.03.17.20037432"},{"key":"10.1016\/j.bbi.2020.04.046_b0140","doi-asserted-by":"crossref","first-page":"743","DOI":"10.3389\/fphar.2018.00743","article-title":"Efficacy and safety of Xuebijing injection combined with Ulinastatin as adjunctive therapy on sepsis: a systematic review and meta-analysis","volume":"9","author":"Chen","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbi.2020.04.046_b0145","doi-asserted-by":"crossref","DOI":"10.1172\/JCI137244","article-title":"Clinical and immunologic features in severe and moderate Coronavirus Disease 2019","author":"Chen","year":"2020","journal-title":"J. Clin Invest."},{"key":"10.1016\/j.bbi.2020.04.046_b0150","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1086\/425357","article-title":"Inhalation of nitric oxide in the treatment of severe acute respiratory syndrome: a rescue trial in Beijing","volume":"39","author":"Chen","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bbi.2020.04.046_b0155","doi-asserted-by":"crossref","unstructured":"Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., Xia, J.a., Yu, T., Zhang, X., Zhang, L., 2020c. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395, 507-513.","DOI":"10.1016\/S0140-6736(20)30211-7"},{"key":"10.1016\/j.bbi.2020.04.046_b0160","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1378\/chest.129.6.1441","article-title":"Treatment of severe acute respiratory syndrome with glucosteroids: the Guangzhou experience","volume":"129","author":"Chen","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.bbi.2020.04.046_b0165","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1183\/09031936.00153211","article-title":"Pre-treatment with mesenchymal stem cells reduces ventilator-induced lung injury","volume":"40","author":"Chimenti","year":"2012","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.bbi.2020.04.046_b0170","unstructured":"China's State Council. February 21, 2020. Press conference on scientific and technological innovation to support epidemic prevention and control. http:\/\/www.scio.gov.cn\/xwfbh\/xwbfbh\/wqfbh\/42311\/42568\/index.htm."},{"key":"10.1016\/j.bbi.2020.04.046_b0175","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/thorax.2003.012658","article-title":"Role of lopinavir\/ritonavir in the treatment of SARS: initial virological and clinical findings","volume":"59","author":"Chu","year":"2004","journal-title":"Thorax"},{"key":"10.1016\/j.bbi.2020.04.046_b0180","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(03)13973-6","article-title":"Treatment of SARS with human interferons","volume":"362","author":"Cinatl","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.bbi.2020.04.046_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104742","article-title":"The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade","volume":"176","author":"Coutard","year":"2020","journal-title":"Antiviral Res."},{"key":"10.1016\/j.bbi.2020.04.046_b0190","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nature00786","article-title":"Angiotensin-converting enzyme 2 is an essential regulator of heart function","volume":"417","author":"Crackower","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.bbi.2020.04.046_b0195","doi-asserted-by":"crossref","unstructured":"De Andrea, M., Ravera, R., Gioia, D., Gariglio, M., Landolfo, S., 2002. The interferon system: an overview. Eur. J. Paediatr. Neurol. 6 Suppl A, A41-A46 and A55-A58.","DOI":"10.1053\/ejpn.2002.0573"},{"key":"10.1016\/j.bbi.2020.04.046_b0200","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.antiviral.2018.03.003","article-title":"Favipiravir as a potential countermeasure against neglected and emerging RNA viruses","volume":"153","author":"Delang","year":"2018","journal-title":"Antiviral Res."},{"key":"10.1016\/j.bbi.2020.04.046_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2020.03.002","article-title":"Arbidol combined with LPV\/r versus LPV\/r alone against Corona Virus Disease 2019: A retrospective cohort study","author":"Deng","year":"2020","journal-title":"J. Infect."},{"key":"10.1016\/j.bbi.2020.04.046_b0210","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1136\/thoraxjnl-2015-206813","article-title":"Human mesenchymal stromal cells decrease the severity of acute lung injury induced by E. coli in the rat","volume":"70","author":"Devaney","year":"2015","journal-title":"Thorax"},{"key":"10.1016\/j.bbi.2020.04.046_b0215","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/path.1560","article-title":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways","volume":"203","author":"Ding","year":"2004","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbi.2020.04.046_b0220","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12906-017-1585-7","article-title":"The Chinese prescription lianhuaqingwen capsule exerts anti-influenza activity through the inhibition of viral propagation and impacts immune function","volume":"17","author":"Ding","year":"2017","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.bbi.2020.04.046_b0225","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/bjh.12031","article-title":"Emerging pathogens and their implications for the blood supply and transfusion transmitted infections","volume":"159","author":"Dodd","year":"2012","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bbi.2020.04.046_b0230","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/637969","article-title":"Effect of lianhuaqingwen capsules on airway inflammation in patients with acute exacerbation of chronic obstructive pulmonary disease","volume":"2014","author":"Dong","year":"2014","journal-title":"Evid. Based Complement Alternat. Med."},{"key":"10.1016\/j.bbi.2020.04.046_b0235","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/B978-0-444-63855-7.00025-3","article-title":"Treatment for smell and taste disorders: a critical review","volume":"164","author":"Doty","year":"2019","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.bbi.2020.04.046_b0240","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2004168117","article-title":"Effectiveness of convalescent plasma therapy in severe COVID-19 patients","author":"Duan","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"10.1016\/j.bbi.2020.04.046_b0245","first-page":"1029","article-title":"Vascular permeability factor\/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis","volume":"146","author":"Dvorak","year":"1995","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbi.2020.04.046_b0250","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1038\/srep01686","article-title":"Inhibition of novel beta coronavirus replication by a combination of interferon-alpha2b and ribavirin","volume":"3","author":"Falzarano","year":"2013","journal-title":"Sci. Rep."},{"issue":"Suppl 1","key":"10.1016\/j.bbi.2020.04.046_b0255","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1513\/AnnalsATS.201407-340MG","article-title":"Mechanisms and clinical consequences of acute lung injury","volume":"12","author":"Fanelli","year":"2015","journal-title":"Ann. Am. Thorac. Soc."},{"key":"10.1016\/j.bbi.2020.04.046_b0260","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(20)30116-8","article-title":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","volume":"8","author":"Fang","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.bbi.2020.04.046_b0265","unstructured":"FDA, March 24, 2020. Investigational covid-19 convalescent plasma-emergency INDs. https:\/\/www.fda.gov\/vaccines-blood-biologics\/investigational-new-drug-ind-or-device-exemption-ide-process-cber\/investigational-covid-19-convalescent-plasma-emergency-inds."},{"key":"10.1016\/j.bbi.2020.04.046_b0270","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1056\/NEJM198205273062102","article-title":"Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin","volume":"306","author":"Fehr","year":"1982","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbi.2020.04.046_b0275","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nrd1381","article-title":"Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer","volume":"3","author":"Ferrara","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbi.2020.04.046_b0280","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","article-title":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2","volume":"111","author":"Ferrario","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.bbi.2020.04.046_b0285","doi-asserted-by":"crossref","first-page":"L20","DOI":"10.1152\/ajplung.00300.2011","article-title":"Mechanisms of attenuation of abdominal sepsis induced acute lung injury by ascorbic acid","volume":"303","author":"Fisher","year":"2012","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.bbi.2020.04.046_b0290","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1097\/CCM.0b013e3182120cb8","article-title":"Ascorbic acid attenuates lipopolysaccharide-induced acute lung injury","volume":"39","author":"Fisher","year":"2011","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.bbi.2020.04.046_b0295","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1126\/science.abb8034","article-title":"Misguided drug advice for COVID-19","volume":"367","author":"FitzGerald","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.bbi.2020.04.046_b0300","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1479-5876-12-32","article-title":"Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis","volume":"12","author":"Fowler","year":"2014","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbi.2020.04.046_b0305","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.antiviral.2013.09.015","article-title":"Favipiravir (T-705), a novel viral RNA polymerase inhibitor","volume":"100","author":"Furuta","year":"2013","journal-title":"Antiviral. Res."},{"key":"10.1016\/j.bbi.2020.04.046_b0310","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1128\/AAC.49.3.981-986.2005","article-title":"Mechanism of action of T-705 against influenza virus","volume":"49","author":"Furuta","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbi.2020.04.046_b0315","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.stem.2018.05.004","article-title":"Mesenchymal stromal cells: clinical challenges and therapeutic opportunities","volume":"22","author":"Galipeau","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bbi.2020.04.046_b0320","doi-asserted-by":"crossref","first-page":"72","DOI":"10.5582\/bst.2020.01047","article-title":"Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies","volume":"14","author":"Gao","year":"2020","journal-title":"Biosci. Trends"},{"key":"10.1016\/j.bbi.2020.04.046_b0325","doi-asserted-by":"crossref","unstructured":"Gautret, P., Lagier, J.C., Parola, P., Hoang, V.T., Meddeb, L., Mailhe, M., Doudier, B., Coujon, J., Giordanengo, V., Vieira, V.E., Dupont, H.T., Honore, S., Colson, P., Chabriere, E., La Scola, B., Rolain, J.M., Brouqui, P., Raoult D., 2020. Hydrochloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int. J. Antimicrob. Agents 10.1016\/j.ijantimicag.2020.105949.","DOI":"10.1101\/2020.03.16.20037135"},{"key":"10.1016\/j.bbi.2020.04.046_b0330","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1099\/0022-1317-81-10-2341","article-title":"Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures","volume":"81","author":"Goodbourn","year":"2000","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.bbi.2020.04.046_b0335","doi-asserted-by":"crossref","first-page":"E988","DOI":"10.3390\/nu12040988","article-title":"Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths","volume":"12","author":"Grant","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.bbi.2020.04.046_b0340","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2007016","article-title":"Compassionate use of remdesivir for patients with severe COVID-19","author":"Grein","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbi.2020.04.046_b0345","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1056\/NEJMra051884","article-title":"Inhaled nitric oxide therapy in adults","volume":"353","author":"Griffiths","year":"2005","journal-title":"N. Eng. J. Med."},{"key":"10.1016\/j.bbi.2020.04.046_b0350","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical Characteristics of Coronavirus Disease 2019 in China","author":"Guan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbi.2020.04.046_b0355","volume":"9","author":"Guo","year":"2020","journal-title":"J. Am. Heart. Assoc."},{"key":"10.1016\/j.bbi.2020.04.046_b0360","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1136\/thoraxjnl-2011-201176","article-title":"Mesenchymal stem cells enhance survival and bacterial clearance in murine Escherichia coli pneumonia","volume":"67","author":"Gupta","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.bbi.2020.04.046_b0365","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.4049\/jimmunol.179.3.1855","article-title":"Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice","volume":"179","author":"Gupta","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbi.2020.04.046_b0370","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nm1001","article-title":"Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques","volume":"10","author":"Haagmans","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbi.2020.04.046_b0375","unstructured":"Hackett, D.W., Mach 17, 2020. China endorses avigan\/favipiravir for COVID-19 disease treatment. https:\/\/www.precisionvaccinations.com\/avigan-favipiravir-t-705-broad-spectrum-inhibitor-viral-rna-polymerase."},{"key":"10.1016\/j.bbi.2020.04.046_b0380","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis","volume":"203","author":"Hamming","year":"2004","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbi.2020.04.046_b0385","doi-asserted-by":"crossref","unstructured":"Han, H., Xie, L., Liu, R., Yang, J., Liu, F., Wu, K., Chen, L., Hou, W., Feng, Y., Zhu, C., 2020a. Analysis of heart injury laboratory parameters in 273 COVID-19 patients in one hospital in Wuhan, China. J. Med. Virol. doi: 10.1002\/jmv.25809.","DOI":"10.1002\/jmv.25809"},{"key":"10.1016\/j.bbi.2020.04.046_b0390","doi-asserted-by":"crossref","unstructured":"Han, H., Yang, L., Liu, R., Liu, F., Wu, K.L., Li, J., Liu, X.H., Zhu, C.L., 2020b. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin. Chem. Lab. Med. doi: 10.1515\/cclm-2020-0188.","DOI":"10.1515\/cclm-2020-0188"},{"key":"10.1016\/j.bbi.2020.04.046_b0395","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/cid\/cir398","article-title":"Early use of glucocorticoids was a risk factor for critical disease and death from pH1N1 infection","volume":"53","author":"Han","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bbi.2020.04.046_b0400","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s40262-013-0072-7","article-title":"Pharmacokinetics and pharmacodynamics of recombinant human angiotensin-converting enzyme 2 in healthy human subjects","volume":"52","author":"Haschke","year":"2013","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.bbi.2020.04.046_b0405","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/804940","article-title":"Xuebijing protects rats from sepsis challenged with acinetobacter baumannii by promoting annexin A1 expression and inhibiting proinflammatory cytokines secretion","volume":"2013","author":"He","year":"2013","journal-title":"Evid. Based Complement Alternat. Med."},{"key":"10.1016\/j.bbi.2020.04.046_b0410","doi-asserted-by":"crossref","unstructured":"Hemil\u00e4, H., Chalker, E., 2013. Vitamin C for preventing and treating the common cold. Cochrane Database Syst. Rev. CD000980. doi: 10.1002\/14651858.CD000980.pib4.","DOI":"10.1002\/14651858.CD000980.pub4"},{"key":"10.1016\/j.bbi.2020.04.046_b0415","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.3389\/fimmu.2018.01736","article-title":"Immune effects of corticosteroids in sepsis","volume":"9","author":"Heming","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbi.2020.04.046_b0420","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3201\/eid1002.030482","article-title":"Interferon-beta 1a and SARS coronavirus replication","volume":"10","author":"Hensley","year":"2004","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.bbi.2020.04.046_b0425","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1177\/106002809603000215","article-title":"Zinc deficiency and taste disorders","volume":"30","author":"Heyneman","year":"1996","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.bbi.2020.04.046_b0430","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.3389\/fimmu.2019.01090","article-title":"High-dose intravenous immunoglobulin in skin autoimmune disease","volume":"10","author":"Hoffmann","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbi.2020.04.046_b0435","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJMoa2001191","article-title":"First case of 2019 novel coronavirus in the United States","volume":"382","author":"Holshue","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbi.2020.04.046_b0440","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.bbi.2020.04.046_b0445","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/cid\/ciq106","article-title":"Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection","volume":"52","author":"Hung","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bbi.2020.04.046_b0450","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1189\/jlb.0907650","article-title":"Antiviral NK cell responses in HIV infection: I. NK cell receptor genes as determinants of HIV resistance and progression to AIDS","volume":"84","author":"Iannello","year":"2008","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bbi.2020.04.046_b0455","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature03712","article-title":"Angiotensin-converting enzyme 2 protects from severe acute lung failure","volume":"436","author":"Imai","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.bbi.2020.04.046_b0460","unstructured":"Inovio. press release at March 03, 2020. Inovio Accelerates Timeline for COVID-19 DNA Vaccine INO-4800. http:\/\/ir.inovio.com\/news-and-media\/news\/press-release-details\/2020\/Inovio-Accelerates-Timeline-for-COVID-19-DNA-Vaccine-INO-4800\/default.aspx."},{"key":"10.1016\/j.bbi.2020.04.046_b0465","unstructured":"Italian ANSA news agency. March 13, 2020. 3 patients get better on arthritis drug. http:\/\/www.ansa.it\/english\/news\/general_news\/2020\/03\/13\/3-patients-get-better-on-arthritis-drug_90d4764d-d93f-463e-ab07-168b34b084d0.html."},{"key":"10.1016\/j.bbi.2020.04.046_b0470","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1161\/01.HYP.0000124667.34652.1a","article-title":"Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors","volume":"43","author":"Ishiyama","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.bbi.2020.04.046_b0475","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2005.02834.x","article-title":"Clinical uses of intravenous immunoglobulin","volume":"142","author":"Jolles","year":"2005","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.bbi.2020.04.046_b0480","article-title":"A comprehensive literature review on the clinical presentation, and management of the pandemic coronavirus disease 19 (COVID-19)","volume":"12","author":"Kakodkar","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.bbi.2020.04.046_b0485","doi-asserted-by":"crossref","DOI":"10.1016\/S2215-0366(20)30047-X","article-title":"The mental health of medical workers in Wuhan, China dealing with the 2019 novel coronavirus","volume":"7","author":"Kang","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.bbi.2020.04.046_b0490","doi-asserted-by":"crossref","first-page":"H1351","DOI":"10.1152\/ajpheart.01186.2004","article-title":"Effects of spironolactone and eprosartan on cardiac remodeling and angiotensin-converting enzyme isoforms in rats with experimental heart failure","volume":"289","author":"Karram","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbi.2020.04.046_b0495","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1365-2249.1991.tb05794.x","article-title":"Intravenous immunoglobulins (IVIg) in the treatment of autoimmune diseases","volume":"86","author":"Kaveri","year":"1991","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.bbi.2020.04.046_b0500","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ijid.2004.04.012","article-title":"Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound","volume":"8","author":"Keyaerts","year":"2004","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.bbi.2020.04.046_b0505","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.bbrc.2004.08.085","article-title":"In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine","volume":"323","author":"Keyaerts","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbi.2020.04.046_b0510","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40902-020-00254-7","article-title":"Dysosmia and dysgeusia due to the 2019 novel coronavirus; a hypothesis that needs further investigation","volume":"42","author":"Keyhan","year":"2020","journal-title":"Maxillofac Plast. Reconstr. Surg."},{"key":"10.1016\/j.bbi.2020.04.046_b0515","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s13054-017-1823-x","article-title":"A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome","volume":"21","author":"Khan","year":"2017","journal-title":"Crit. Care"},{"key":"10.1016\/j.bbi.2020.04.046_b0520","article-title":"Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development","volume":"102743","author":"Kim","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bbi.2020.04.046_b0525","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3851\/IMP3002","article-title":"Combination therapy with lopinavir\/ritonavir, ribavirin and interferon-\u03b1 for middle east respiratory syndrome","volume":"21","author":"Kim","year":"2016","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.bbi.2020.04.046_b0530","doi-asserted-by":"crossref","first-page":"L1003","DOI":"10.1152\/ajplung.00180.2011","article-title":"Human mesenchymal stem cells reduce mortality and bacteremia in gram-negative sepsis in mice in part by enhancing the phagocytic activity of blood monocytes","volume":"302","author":"Krasnodembskaya","year":"2012","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.bbi.2020.04.046_b0535","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbi.2020.04.046_b0540","doi-asserted-by":"crossref","unstructured":"Lane, J.C.E., Weaver, J., Kostka, K., Duarte-Salles, T., Abrahao, M.T.F., Alghoul, H., Alser, O., Alshammari, T.M., Biedermann, P., Burn, E., Casajust, P., Conover, M., Culhane, A.C., Davydov, A., DuVall, S.L., Dymshyts, D., Bertol\u00edn, S.F., Fi\u0161ter, K., Hardin, J., Hester, L., Hripcsak, G., Kent, S., Khosla, S., Kolovos, S., Lambert, C.G., ver der Lei, J., Londhe, A.A., Lynch, K.E., Makadia, R., Margulis, A.V., Matheny, M.E., Mehta, P., Morales, D.R., Morgan-Stewart, H., Mosseveld, M., Newby, D., Nyberg,F., Ostropolets, A., Park, R.W., Prats-Uribe, A., Rao, G.A., Reich, C., Reps, J., Rijnbeek, P., Sathappan, S.M.K., Schuemie, M., Seager, S., Sena, A., Shoaibi, A., Spotnitz, M., Suchard, M.A., Swerdel, J., Torre, C.O., Vizcaya, D., Wen, H., de Wilde, M., You, S.C., Zhang, L., Zhuk, O., Ryan, P., Prieto-Alhambra, D., 2020., Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for COVID-19: a multinational, network cohort and self-controlled case series study. medRxiv doi.org\/10.1101\/2020.04.08.20054551.","DOI":"10.1016\/S2665-9913(20)30276-9"},{"key":"10.1016\/j.bbi.2020.04.046_b0545","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","article-title":"Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study","volume":"371","author":"Le Blanc","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.bbi.2020.04.046_b0550","doi-asserted-by":"crossref","DOI":"10.1007\/s00405-020-05965-1","article-title":"Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study","author":"Lechien","year":"2020","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"10.1016\/j.bbi.2020.04.046_b0555","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/imr.12793","article-title":"Cellular therapy: Adoptive immunotherapy with expanded natural killer cells","volume":"290","author":"Lee","year":"2019","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bbi.2020.04.046_b0560","doi-asserted-by":"crossref","unstructured":"Lei, C., Fu, W., Qian, K., Li, T., Zhang, S., Ding, M., Hu, S., 2020. Potent neutralization of 2019 novel coronavirus by recombinant ACE2-Ig. bioRxiv, 2020.2002.2001.929976.","DOI":"10.1101\/2020.02.01.929976"},{"key":"10.1016\/j.bbi.2020.04.046_b0565","doi-asserted-by":"crossref","first-page":"216","DOI":"10.14336\/AD.2020.0228","article-title":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia","volume":"11","author":"Leng","year":"2020","journal-title":"Aging Dis."},{"key":"10.1016\/j.bbi.2020.04.046_b0570","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1001\/jama.290.3.374","article-title":"Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome","volume":"290","author":"Lew","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.bbi.2020.04.046_b0575","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/irv.12456","article-title":"Effect of low-to-moderate-dose corticosteroids on mortality of hospitalized adolescents and adults with influenza A(H1N1)pdm09 viral pneumonia","volume":"11","author":"Li","year":"2017","journal-title":"Influenza Other Respir. Viruses"},{"key":"10.1016\/j.bbi.2020.04.046_b0580","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1476-9255-9-33","article-title":"Human umbilical cord mesenchymal stem cells reduce systemic inflammation and attenuate LPS-induced acute lung injury in rats","volume":"9","author":"Li","year":"2012","journal-title":"J. Inflamm. (Lond)"},{"key":"10.1016\/j.bbi.2020.04.046_b0585","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.bbi.2020.04.046_b0590","article-title":"Caution on kidney dysfunctions of COVID-19 patients","author":"Li","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.bbi.2020.04.046_b0595","article-title":"Vicarious traumatization in the general public, members, and non-members of medical teams aiding in COVID-19 control","author":"Li","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2020.04.046_b0600","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1128\/AAC.00339-08","article-title":"Pharmacokinetics of hydroxychloroquine and its clinical implications in chemoprophylaxis against malaria caused by Plasmodium vivax","volume":"53","author":"Lim","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbi.2020.04.046_b0605","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2020-321013","article-title":"Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection","author":"Lin","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.bbi.2020.04.046_b0610","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41421-020-0156-0","article-title":"Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro","volume":"6","author":"Liu","year":"2020","journal-title":"Cell Discov."},{"key":"10.1016\/j.bbi.2020.04.046_b0615","doi-asserted-by":"crossref","unstructured":"Liu, J., Liu, Y., Xiang, P., Pu, L., Xiong, H., Li, C., Zhang, M., Tan, J., Xu, Y., Song, R., Song, M., Wang, L., Zhang, W., Han, B., Yang, L., Wang, X., Zhou, G., Zhang, T., Li, B., Wang, Y., Chen, Z., Wang, X., 2020b. Neutrophil-to-lymphocyte ratio predicts severe illness patients with 2019 novel coronavirus in the early stage. medRxiv, 2020.2002.2010.20021584.","DOI":"10.1101\/2020.02.10.20021584"},{"key":"10.1016\/j.bbi.2020.04.046_b0620","article-title":"Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province","author":"Liu","year":"2020","journal-title":"Chin. Med. J. (Engl)."},{"key":"10.1016\/j.bbi.2020.04.046_b0625","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s11427-020-1643-8","article-title":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury","volume":"63","author":"Liu","year":"2020","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.bbi.2020.04.046_b0630","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1146\/annurev.immunol.23.021704.115633","article-title":"IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors","volume":"23","author":"Liu","year":"2005","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bbi.2020.04.046_b0635","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1001\/jama.290.24.3222","article-title":"Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study","volume":"290","author":"Loutfy","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.bbi.2020.04.046_b0640","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.bbi.2020.04.046_b0645","doi-asserted-by":"crossref","first-page":"326ra321","DOI":"10.1126\/scitranslmed.aaf1061","article-title":"Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo","volume":"8","author":"Luke","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbi.2020.04.046_b0650","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1182\/blood.V88.1.184.184","article-title":"High doses of immunoglobulin G attenuate immune aggregate-mediated complement activation by enhancing physiologic cleavage of C3b in C3bn-IgG complexes","volume":"88","author":"Lutz","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.bbi.2020.04.046_b0655","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1002\/stem.1681","article-title":"Concise review: the surface markers and identity of human mesenchymal stem cells","volume":"32","author":"Lv","year":"2014","journal-title":"Stem Cells"},{"key":"10.1016\/j.bbi.2020.04.046_b0660","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/infdis\/jiu396","article-title":"The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis","volume":"211","author":"Mair-Jenkins","year":"2015","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.bbi.2020.04.046_b0665","unstructured":"Mak, E. March 18, 2020. China approves first homegrown COVID-19 vaccine to enter clinical trials. https:\/\/www.bioworld.com\/articles\/433791-china-approves-first-homegrown-covid-19-vaccine-to-enter-clinical-trials."},{"key":"10.1016\/j.bbi.2020.04.046_b0670","doi-asserted-by":"crossref","unstructured":"Mao, L., Wang, M., Chen, S., He, Q., Chang, J., Hong, C., Zhou, Y., Wang, D., Li, Y., Jin, H., Hu, B., 2020. Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: a retrospective case series study. medRxiv, 2020.2002.2022.20026500.","DOI":"10.1101\/2020.02.22.20026500"},{"key":"10.1016\/j.bbi.2020.04.046_b0675","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1073\/pnas.89.8.3325","article-title":"Human autoantibodies reactive with synthetic autoantigens from T-cell receptor beta chain","volume":"89","author":"Marchalonis","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbi.2020.04.046_b0680","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1089\/ars.2013.5205","article-title":"Role of vitamin C in the function of the vascular endothelium","volume":"19","author":"May","year":"2013","journal-title":"Antioxid. Redox. Signal."},{"key":"10.1016\/j.bbi.2020.04.046_b0685","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.bbi.2020.04.046_b0690","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1164\/rccm.201001-0010OC","article-title":"Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis","volume":"182","author":"Mei","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.bbi.2020.04.046_b0695","doi-asserted-by":"crossref","unstructured":"Microft-West, C., Su, D., Elli, S., Guimond, S., Miller, G., Turnbull, J., Yates, E., Guerrini, M., Fernig, D., Lima, M., Skidmore, M., 2020. The 2019 coronavirus (SARS-CoV-2) surface protein (Spike) S1 receptor domain undergoes conformational change upon heparin binding. bioRxiv doi:10.1101\/2020.02.29.971093.","DOI":"10.1101\/2020.02.29.971093"},{"key":"10.1016\/j.bbi.2020.04.046_b0700","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0166-3542(87)90079-9","article-title":"Protective effect of recombinant murine interferon beta against mouse hepatitis virus infection","volume":"8","author":"Minagawa","year":"1987","journal-title":"Antiviral Res."},{"key":"10.1016\/j.bbi.2020.04.046_b0705","unstructured":"Moderna. Press release at March 16, 2020a. Moderna announces first participant dosed in NIH-led phase 1 study of mRNA vaccine (mRNA-1273) against novel coronavirus. https:\/\/investors.modernatx.com\/news-releases\/news-release-details\/moderna-announces-first-participant-dosed-nih-led-phase-1-study."},{"key":"10.1016\/j.bbi.2020.04.046_b0710","unstructured":"Moderna. Press release at April 16, 2020b. Moderna announces award from U.S. government agency BARDA for up to $483 million to accelerate development of mRNA vaccine (mRNA-1273) against novel coronavirus. https:\/\/investors.modernatx.com\/news-releases\/news-release-details\/moderna-announces-award-us-government-agency-barda-483-million."},{"key":"10.1016\/j.bbi.2020.04.046_b0715","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.3390\/nu5083131","article-title":"Vitamin C: a novel regulator of neutrophil extracellular trap formation","volume":"5","author":"Mohammed","year":"2013","journal-title":"Nutrients"},{"key":"10.1016\/j.bbi.2020.04.046_b0720","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1056\/NEJMp2000929","article-title":"A novel coronavirus emerging in China - key questions for impact assessment","volume":"382","author":"Munster","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbi.2020.04.046_b0725","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1093\/jn\/114.9.1602","article-title":"Stress-induced change in tissue levels of ascorbic acid and histamine in rats","volume":"114","author":"Nakano","year":"1984","journal-title":"J. Nutr."},{"key":"10.1016\/j.bbi.2020.04.046_b0730","unstructured":"National Health and Family Planning Commission of China (NHPFC). March 04, 2020. Chinese clinical guidance for COVID-19 pneumonia diagnosis and treatment (7th edition). http:\/\/kjfy.meetingchina.org\/msite\/news\/show\/cn\/3337.html."},{"key":"10.1016\/j.bbi.2020.04.046_b0735","unstructured":"National Institutes of Health (NIH). March 16, 2020. NIH clinical trial of investigational vaccine for COVID-19 begins. https:\/\/www.nih.gov\/news-events\/news-releases\/nih-clinical-trial-investigational-vaccine-covid-19-begins. http:\/\/tribuneonlineng.com\/china-approves-use-of-roche-drug-in-battle-against-coronavirus-complications\/."},{"issue":"Suppl 1","key":"10.1016\/j.bbi.2020.04.046_b0745","doi-asserted-by":"crossref","first-page":"i21","DOI":"10.1136\/ard.59.suppl_1.i21","article-title":"Anti-interleukin 6 receptor antibody treatment in rheumatic disease","volume":"59","author":"Nishimoto","year":"2000","journal-title":"Ann. Rhum. Dis."},{"key":"10.1016\/j.bbi.2020.04.046_b0750","unstructured":"Novavax, Press Release April 08, 2020. Novavax identifies coronavirus vaccine candidate: accelerates initiation of first-in-human trial to mid-May. https:\/\/ir.novavax.com\/news-releases\/news-release-details\/novavax-identifies-coronavirus-vaccine-candidate-accelerates."},{"key":"10.1016\/j.bbi.2020.04.046_b0755","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.immuni.2012.03.014","article-title":"JAK and STAT signaling molecules in immunoregulation and immune-mediated disease","volume":"36","author":"O'Shea","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.bbi.2020.04.046_b0760","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.antiviral.2014.02.014","article-title":"Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model","volume":"105","author":"Oestereich","year":"2014","journal-title":"Antiviral Res."},{"key":"10.1016\/j.bbi.2020.04.046_b0765","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1186\/s13054-014-0460-x","article-title":"Vitamin C revisited","volume":"18","author":"Oudemans-van Straaten","year":"2014","journal-title":"Crit. Care"},{"key":"10.1016\/j.bbi.2020.04.046_b0770","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2019.104597","article-title":"The prophylactic and therapeutic activity of a broadly active ribonucleoside analog in a murine model of intranasal venezuelan equine encephalitis virus infection","volume":"171","author":"Painter","year":"2019","journal-title":"Antiviral Res."},{"key":"10.1016\/j.bbi.2020.04.046_b0775","doi-asserted-by":"crossref","DOI":"10.1007\/s00134-020-06026-1","article-title":"Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis","author":"Pan","year":"2020","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.bbi.2020.04.046_b0780","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/nri.2017.105","article-title":"Neutrophil extracellular traps in immunity and disease","volume":"18","author":"Papayannopoulos","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbi.2020.04.046_b0785","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/S0140-6736(00)04904-7","article-title":"An overview of the immune system","volume":"357","author":"Parkin","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.bbi.2020.04.046_b0790","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/0140-6736(91)92033-X","article-title":"Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension","volume":"338","author":"Pepke-Zaba","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.bbi.2020.04.046_b0795","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMp2008017","article-title":"Mental Health and the Covid-19 pandemic","author":"Pfefferbaum","year":"2020","journal-title":"N. Eng. J. Med."},{"key":"10.1016\/j.bbi.2020.04.046_b0800","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2119\/2008-00033.Prasad","article-title":"Zinc in human health: effect of zinc on immune cells","volume":"14","author":"Prasad","year":"2008","journal-title":"Mol. Med."},{"key":"10.1016\/j.bbi.2020.04.046_b0805","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3324\/haematol.11240","article-title":"Generation of CD4+ or CD8+ regulatory T cells upon mesenchymal stem cell-lymphocyte interaction","volume":"92","author":"Prevosto","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.bbi.2020.04.046_b0810","article-title":"Dysregulation of immune response in patients with COVID-19 in Wuhan, China","author":"Qin","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bbi.2020.04.046_b0815","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2147\/DDDT.S100302","article-title":"Profile of sarilumab and its potential in the treatment of rheumatoid arthritis","volume":"11","author":"Raimondo","year":"2017","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.bbi.2020.04.046_b0820","unstructured":"Regeneron. March 16, 2020. REGENERON AND SANOFI BEGIN GLOBAL KEVZARA\u00ae (SARILUMAB) CLINICAL TRIAL PROGRAM IN PATIENTS WITH SEVERE COVID-19. https:\/\/investor.regeneron.com\/news-releases\/news-release-details\/regeneron-and-sanofi-begin-global-kevzarar-sarilumab-clinical\/."},{"key":"10.1016\/j.bbi.2020.04.046_b0825","article-title":"Traditional Chinese medicine for COVID-19 treatment","volume":"155","author":"Ren","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbi.2020.04.046_b0830","doi-asserted-by":"crossref","first-page":"6233","DOI":"10.3390\/v7122934","article-title":"Identification of a new ribonucleoside inhibitor of Ebola Virus replication","volume":"7","author":"Reynard","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.bbi.2020.04.046_b0835","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMra050541","article-title":"Antiinflammatory action of glucocorticoids\u2013new mechanisms for old drugs","volume":"353","author":"Rhen","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbi.2020.04.046_b0840","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1016\/S0140-6736(20)30304-4","article-title":"Baricitinib as potential treatment for 2019-nCoV acute respiratory disease","volume":"395","author":"Richardson","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.bbi.2020.04.046_b0845","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.4940","article-title":"Convalescent plasma to treat COVID-19: possibilities and challenges","author":"Roback","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.bbi.2020.04.046_b0850","unstructured":"Routley, N. April 01, 2020. Every vaccine and treatment in development for COVID-19, so far. https:\/\/www.visualcapitalist.com\/every-vaccine-treatment-covid-19-so-far\/."},{"key":"10.1016\/j.bbi.2020.04.046_b0855","doi-asserted-by":"crossref","unstructured":"Ruan, Q., Yang, K., Wang, W., Jiang, L., Song, J., 2020. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. doi: 10.1007\/s00134-020-05991-x.","DOI":"10.1007\/s00134-020-05991-x"},{"key":"10.1016\/j.bbi.2020.04.046_b0860","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104761","article-title":"Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)","author":"Runfeng","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbi.2020.04.046_b0865","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.virol.2004.08.011","article-title":"Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated coronavirus (SARS-CoV)","volume":"329","author":"Sainz","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.bbi.2020.04.046_b0870","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.2147\/DDDT.S99696","article-title":"Spotlight on tocilizumab and its potential in the treatment of systemic sclerosis","volume":"10","author":"Sakkas","year":"2016","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.bbi.2020.04.046_b0875","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1074-7613(00)80003-5","article-title":"An antiviral mechanism of nitric oxide: inhibition of a viral protease","volume":"10","author":"Saura","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.bbi.2020.04.046_b0880","first-page":"722","article-title":"Effects of chloroquine on viral infections: an old drug against today's diseases? Lancet Infect","volume":"3","author":"Savarino","year":"2003","journal-title":"Dis."},{"key":"10.1016\/j.bbi.2020.04.046_b0885","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1473-3099(06)70361-9","article-title":"New insights into the antiviral effects of chloroquine","volume":"6","author":"Savarino","year":"2006","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.bbi.2020.04.046_b0890","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0092-8674(94)90267-4","article-title":"NO at work","volume":"78","author":"Schmidt","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.bbi.2020.04.046_b0895","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12985-019-1182-0","article-title":"Coronavirus envelope protein: current knowledge","volume":"16","author":"Schoeman","year":"2019","journal-title":"Virol J."},{"key":"10.1016\/j.bbi.2020.04.046_b0900","unstructured":"ScienceDaily. April 02, 2020. COVID-19 vaccine candidate shows promise, research shows. https:\/\/www.sciencedaily.com\/releases\/2020\/04\/200402144508.htm."},{"key":"10.1016\/j.bbi.2020.04.046_b0905","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1146\/annurev.micro.55.1.255","article-title":"Viruses and interferons","volume":"55","author":"Sen","year":"2001","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.bbi.2020.04.046_b0910","doi-asserted-by":"crossref","first-page":"eaal3653","DOI":"10.1126\/scitranslmed.aal3653","article-title":"Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses","volume":"9","author":"Sheahan","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbi.2020.04.046_b0915","doi-asserted-by":"crossref","unstructured":"Sheahan, T.P., Sims, A.C., Zhou, S., Graham, R.L., Pruijssers, A.J., Agostini, M.L., Leist, S.R., Sch\u00e4fer, A., Dinnon, K.H., Stevens, L.J., Chappell, J.D., Lu, X., Hughes, T.M., George, A.S., Hill, C.S., Montgomery, S.A., Brown, A.J., Bluemling, G.R., Natchus, M.G., Saindane, M., Kolykhalov, A.A., Painter, G., Harcourt, J., Tamin, A., Thornburg, N.J., Swanstrom, R., Denison, M.R., Baric, R.S., 2020. An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice. Sci. Transl. Med. 2020 Apr 6. doi: 10.1126\/scitranslmed.abb5883.","DOI":"10.1126\/scitranslmed.abb5883"},{"key":"10.1016\/j.bbi.2020.04.046_b0920","article-title":"Knowledge and attitudes of medical staff in Chinese psychiatric hospitals regarding COVID-19","volume":"4","author":"Shi","year":"2020","journal-title":"Brain Behav. Immun. Health"},{"key":"10.1016\/j.bbi.2020.04.046_b0925","first-page":"E029","article-title":"Progress and challenge of vaccine development against 2019 novel coronavirus (2019-nCoV)","volume":"54","author":"Shi","year":"2020","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"},{"key":"10.1016\/j.bbi.2020.04.046_b0930","first-page":"56","article-title":"Cytokine release syndrome. J. Immunother","volume":"6","author":"Shimabukuro-Vornhagen","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.bbi.2020.04.046_b0935","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1021\/acs.jmedchem.6b01594","article-title":"Discovery and synthesis of a phosphoramidate prodrug of a pyrrolo[2,1-f][triazin-4-amino] adenine C-nucleoside (GS-5734) for the treatment of Ebola and emerging viruses","volume":"60","author":"Siegel","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbi.2020.04.046_b0940","doi-asserted-by":"crossref","first-page":"519","DOI":"10.7326\/M15-0715","article-title":"Corticosteroid therapy for patients hospitalized with community-acquired pneumonia: a systematic review and meta-analysis","volume":"163","author":"Siemieniuk","year":"2015","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bbi.2020.04.046_b0945","article-title":"Experimental treatment with favipiravir for Ebola Virus disease (the JIKI Trial): A historically controlled, single-arm proof-of-concept trial in Guinea","volume":"13","author":"Sissoko","year":"2016","journal-title":"PLoS Med."},{"key":"10.1016\/j.bbi.2020.04.046_b0950","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.antiviral.2014.01.012","article-title":"Post-exposure efficacy of oral T-705 (Favipiravir) against inhalational Ebola virus infection in a mouse model","volume":"104","author":"Smither","year":"2014","journal-title":"Antiviral Res."},{"key":"10.1016\/j.bbi.2020.04.046_b0955","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1089\/jir.1989.9.285","article-title":"Comparative susceptibility of respiratory viruses to recombinant interferons-alpha 2b and -beta","volume":"9","author":"Sperber","year":"1989","journal-title":"J. Interferon Res."},{"key":"10.1016\/j.bbi.2020.04.046_b0960","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030343","article-title":"SARS: systematic review of treatment effects","volume":"3","author":"Stockman","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.bbi.2020.04.046_b0965","doi-asserted-by":"crossref","unstructured":"Strabelli, T.M.V., Uip, D.E., 2020. COVID-19 and the Heart. Arq. Bras. Cardiol. doi: 10.36660\/abc.20200209.","DOI":"10.36660\/abc.20200209"},{"key":"10.1016\/j.bbi.2020.04.046_b0970","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1086\/382597","article-title":"Severe acute respiratory syndrome-related coronavirus is inhibited by interferon- alpha","volume":"189","author":"Str\u00f6her","year":"2004","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.bbi.2020.04.046_b0975","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.tim.2016.03.003","article-title":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses","volume":"24","author":"Su","year":"2016","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.bbi.2020.04.046_b0980","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3109\/01902140903312123","article-title":"Xuebijing protects against lipopolysaccharide-induced lung injury in rabbits","volume":"36","author":"Sun","year":"2010","journal-title":"Exp. Lung Res."},{"key":"10.1016\/j.bbi.2020.04.046_b0985","doi-asserted-by":"crossref","first-page":"581","DOI":"10.3201\/eid1004.030458","article-title":"Inhibition of SARS coronavirus infection in vitro with clinically approved antiviral drugs","volume":"10","author":"Tan","year":"2004","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.bbi.2020.04.046_b0990","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Tang","year":"2020","journal-title":"J Thromb. Haemost."},{"key":"10.1016\/j.bbi.2020.04.046_b0995","article-title":"Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy","author":"Tang","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.bbi.2020.04.046_b1000","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001176","article-title":"Zn2+ inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture","volume":"6","author":"te Velthuis","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bbi.2020.04.046_b1005","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1164\/ajrccm.164.9.2011071","article-title":"Vascular endothelial growth factor may contribute to increased vascular permeability in acute respiratory distress syndrome","volume":"164","author":"Thickett","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.bbi.2020.04.046_b1010","unstructured":"Third People's Hospital of Shenzhen. February 14, 2020. Familavir is more effective than Lopinavir\/ritonavir in the treatment of COVID-19 (in Chinese). http:\/\/www.szdsyy.com\/News\/0a6c1e58-e3d0-4cd1-867a-d5524bc59cd6.html."},{"key":"10.1016\/j.bbi.2020.04.046_b1015","doi-asserted-by":"crossref","first-page":"S253","DOI":"10.1097\/01.CCM.0000057900.19201.55","article-title":"Glucocorticoids and acute lung injury","volume":"31","author":"Thompson","year":"2003","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.bbi.2020.04.046_b1020","doi-asserted-by":"crossref","first-page":"eaax5866","DOI":"10.1126\/scitranslmed.aax5866","article-title":"Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia","volume":"11","author":"Toots","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbi.2020.04.046_b1025","first-page":"55","article-title":"Chloroquine and hydroxychloroquine equally affect tumor necrosis factor-alpha, interleukin 6, and interferon-gamma production by peripheral blood mononuclear cells","volume":"24","author":"van den Borne","year":"1997","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.bbi.2020.04.046_b1030","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.04.004","article-title":"Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2","author":"Monteil","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.bbi.2020.04.046_b1035","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/ni1582","article-title":"Functions of natural killer cells","volume":"9","author":"Vivier","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbi.2020.04.046_b1040","first-page":"266","article-title":"Acute renal failure resulting from intravenous immunoglobulin therapy","volume":"63","author":"Wajanaponsan","year":"2004","journal-title":"Hawaii Med. J."},{"key":"10.1016\/j.bbi.2020.04.046_b1045","doi-asserted-by":"crossref","unstructured":"Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., Zhao, Y., Li, Y., Wang, X., Peng, Z., 2020a. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel coronavirus-infected pneumonia in Wuhan, China. JAMA doi: 10.1001\/jama.2020.1585.","DOI":"10.1001\/jama.2020.1585"},{"key":"10.1016\/j.bbi.2020.04.046_b1050","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiaa150","article-title":"Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia","author":"Wang","year":"2020","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.bbi.2020.04.046_b1055","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.bbi.2020.04.046_b1060","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13063-016-1282-8","article-title":"Xuebijing injection in the treatment of severe pneumonia: study protocol for a randomized controlled trial","volume":"17","author":"Wang","year":"2016","journal-title":"Trials"},{"key":"10.1016\/j.bbi.2020.04.046_b1065","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1056\/NEJM198902093200606","article-title":"Tissue destruction by neutrophils","volume":"320","author":"Weiss","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbi.2020.04.046_b1070","unstructured":"World Health Organization(WHO). December 31, 2003. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. https:\/\/www.who.int\/csr\/sars\/country\/table2004_04_21\/en\/."},{"key":"10.1016\/j.bbi.2020.04.046_b1075","unstructured":"World Health Organization(WHO). March 12, 2020a. Coronavirus disease 2019 (COVID-19) situation report \u2013 52. https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/20200312-sitrep-52-covid-19.pdf?sfvrsn=e2bfc9c0_2."},{"key":"10.1016\/j.bbi.2020.04.046_b1080","unstructured":"World Health Organization(WHO). March 30, 2020b. Interim clinical guidance for management of patients with confirmed coronavirus disease (COVID-19). https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/hcp\/clinical-guidance-management-patients.html."},{"key":"10.1016\/j.bbi.2020.04.046_b1085","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1089\/ars.2013.5401","article-title":"Evaluation of vitamin C for adjuvant sepsis therapy","volume":"19","author":"Wilson","year":"2013","journal-title":"Antioxid. Redox. Signal."},{"key":"10.1016\/j.bbi.2020.04.046_b1090","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.bbi.2020.04.046_b1095","doi-asserted-by":"crossref","unstructured":"Wu, Y., Xu, X., Chen, Z., Duan, J., Hashimoto, K., Yang, L., Liu, C., Yang, C., 2020.Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav. Immun. doi: 10.1016\/j.bbi.2020.03.031.","DOI":"10.1016\/j.bbi.2020.03.031"},{"key":"10.1016\/j.bbi.2020.04.046_b1100","doi-asserted-by":"crossref","DOI":"10.1111\/liv.14449","article-title":"Clinical characteristics of Non-ICU hospitalized patients with coronavirus disease 2019 and liver injury: A Retrospective study","author":"Xie","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.bbi.2020.04.046_b1105","first-page":"690","article-title":"Effect of Xuebijing injection pretreatment on expression of pulmonary surfactant-associated protein A in rat alveolar type II epithelial cells induced by lipopolysaccharide","volume":"21","author":"Xu","year":"2009","journal-title":"Zhongguo Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"10.1016\/j.bbi.2020.04.046_b1110","doi-asserted-by":"crossref","first-page":"L131","DOI":"10.1152\/ajplung.00431.2006","article-title":"Prevention of endotoxin-induced systemic response by bone marrow-derived mesenchymal stem cells in mice","volume":"293","author":"Xu","year":"2007","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.bbi.2020.04.046_b1115","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.bbi.2020.04.046_b1120","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2174\/2212798411305010007","article-title":"The role of zinc in the treatment of taste disorders","volume":"5","author":"Yagi","year":"2013","journal-title":"Recent Pat. Food Nutr. Agric."},{"key":"10.1016\/j.bbi.2020.04.046_b1125","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/cr.2012.165","article-title":"Anti-malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal model","volume":"23","author":"Yan","year":"2013","journal-title":"Cell Res."},{"key":"10.1016\/j.bbi.2020.04.046_b1130","doi-asserted-by":"crossref","unstructured":"Yang, X., Yu, Y., Xu, J., Shu, H., Xia, J.a., Liu, H., Wu, Y., Zhang, L., Yu, Z., Fang, M., Yu, T., Wang, Y., Pan, S., Zou, X., Yuan, S., Shang, Y., 2020. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir. Med. doi: 10.1016\/S2213-2600(20)30079-5.","DOI":"10.1016\/S2213-2600(20)30079-5"},{"key":"10.1016\/j.bbi.2020.04.046_b1135","first-page":"E009","article-title":"A pathological report of three COVID-19 cases by minimally invasive autopsies","volume":"49","author":"Yao","year":"2020","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"10.1016\/j.bbi.2020.04.046_b1140","article-title":"Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2","author":"Yin","year":"2020","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.bbi.2020.04.046_b1150","first-page":"673","article-title":"Effect of treatment with Xuebijing injection on serum inflammatory mediators and Th1\/2 of spleen in rats with sepsis","volume":"18","author":"Zhang","year":"2006","journal-title":"Zhongguo Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"10.1016\/j.bbi.2020.04.046_b1170","doi-asserted-by":"crossref","unstructured":"Zhao, Y., Zhao, Z., Wang, Y., Zhou, Y., Ma, Y., Zuo, W., 2020. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov. bioRxiv, 2020.2001.2026.919985.","DOI":"10.1101\/2020.01.26.919985"},{"key":"10.1016\/j.bbi.2020.04.046_b1160","doi-asserted-by":"crossref","DOI":"10.1111\/liv.14455","article-title":"Liver impairment in COVID-19 patients: a retrospective analysis of 115 cases from a single center in Wuhan city, China","author":"Zhang","year":"2020","journal-title":"Liver Int."},{"key":"10.1016\/j.bbi.2020.04.046_b1165","doi-asserted-by":"crossref","DOI":"10.1192\/bjp.2020.84","article-title":"Treatment concerns for psychiatric symptoms in COVID-19-infected patients with or without psychiatric disorders","author":"Zhang","year":"2020","journal-title":"Br. J. Psychiatry."},{"key":"10.1016\/j.bbi.2020.04.046_b1175","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1465-9921-15-39","article-title":"Treatment of acute respiratory distress syndrome with allogeneic adipose-derived mesenchymal stem cells: a randomized, placebo-controlled pilot study","volume":"15","author":"Zheng","year":"2014","journal-title":"Respir. Res."},{"key":"10.1016\/j.bbi.2020.04.046_b1180","doi-asserted-by":"crossref","unstructured":"Zheng, M., Gao, Y., Wang, G., Song, G., Liu, S., Sun, D., Xu, Y., Tian, Z., 2020. Functional exhaustion of antiviral lymphocytes in COVID-19 patients. Cell Mol. Immunol. doi: 10.1038\/s4123-020-0402.","DOI":"10.1038\/s41423-020-0402-2"},{"key":"10.1016\/j.bbi.2020.04.046_b1185","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.bbi.2020.04.046_b1190","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bbi.2020.04.046_b1195","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N. Engl. J. Med."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159120305894?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159120305894?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T08:06:05Z","timestamp":1760169965000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159120305894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":235,"alternative-id":["S0889159120305894"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2020.04.046","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current status of potential therapeutic candidates for the COVID-19 crisis","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2020.04.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}